Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH3 | Q9ULD8 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | TXN | P10599 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | AURKA | O14965 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2270398 | 0.88 | ALDH1A1 (0.43) | MAPTALDH1A1MEN1NPC1RAB9A | |
| SCHEMBL8932050 | 0.85 | NR1H2 (0.46) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL395770 | 0.80 | ALDH1A1 (0.50) | KCNH3MAPTALDH1A1MAPK10MEN1 | |
| SCHEMBL762138 | 0.79 | ALDH1A1 (0.62) | MAPTALDH1A1MEN1RAB9AKMT2A | |
| SCHEMBL916183 | 0.79 | HPGD (0.56) | MAPTALDH1A1MEN1NPC1RAB9A | |
| SCHEMBL916027 | 0.74 | NFKB1 (0.52) | MAPTALDH1A1MEN1NPC1RAB9A | |
| SCHEMBL915383 | 0.74 | MAPT (0.71) | KCNH3MAPTALDH1A1MEN1NPC1 | |
| SCHEMBL916557 | 0.74 | L3MBTL1 (0.47) | MAPTALDH1A1MEN1NPC1RAB9A | |
| SCHEMBL917356 | 0.74 | RAB9A (0.49) | MAPTALDH1A1MEN1NPC1RAB9A | |
| SCHEMBL915691 | 0.74 | NR1H2 (0.44) | MAPTMEN1NPC1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11306060-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. (KR) | 2022-04-19 | — | — | US | disclosed |
| CN-109071449-B | Compound and organic electronic element comprising same | 株式会社LG化学 | 2022-04-15 | — | — | CN | disclosed |
| CN-110049964-B | Novel compound and organic light emitting device using the same | 株式会社LG化学 | 2022-03-22 | — | — | CN | disclosed |
| EP-3428152-B1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2021-11-03 | — | — | EP | disclosed |
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
| EP-3428152-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG Chem, Ltd. (KR) | 2019-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | KCNH3 694/4885MAPT 1486/4885ALDH1A1 1103/4885 |
| US-11306060-B2 | Compound and organic electronic element comprising same | OR10J3, ETV6, BMI1 | KCNH3 459/4885MAPT 1633/4885ALDH1A1 1193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.